×

Access Whitepaper

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Part 6: Going Remote During COVID-19: Considerations When Moving Studies Out of the Clinic Setting

May 14, 2020
 In this webinar, our panel of experts discuss what you need to know about the impact of COVID-19 on your clinical trials:
  • Informed consent: what’s allowed and what’s practical in obtaining consent remotely, where does electronic consent come in, and whether participant compensation needs to be modified
  • How do IRBs consider the review of “virtual” clinical trials?
  • What do sponsors consider when deciding whether study visits can be conducted remotely, both when planning ahead, and when reacting to urgent issues?
Previous Flipbook
Part 7: Imagining the Future State of Clinical Research
Part 7: Imagining the Future State of Clinical Research

Next Flipbook
Part 5: Maintaining Data Collection and Data Validity Amidst Major Study Changes
Part 5: Maintaining Data Collection and Data Validity Amidst Major Study Changes

Request a Genetics in Clinical Trials training session

What You'll Learn